Eckert & Ziegler BEBIG is the exclusive manufacturer of Ru-106 (Ruthenium-106) Ophthalmic Plaques, used to treat uveal melanoma and retinoblastoma.
The plaques consist of a thin film of Ru-106, a beta emitter, encapsulated within pure silver sheets with a total thickness of only 1mm. Due to its half-life of 374 days, the Ru-106 Ophthalmic Plaques can be used a number of times within one year.
SagiNova® HDR afterloader was designed to address today´s needs for HDR brachytheraphy applications regarding safetly, seamless workflows, and cost efficiency. With the help of applicators and catheters, a very small radiation source is driven from a shielded safe – located inside the afterloader – directly into or next to the tumour.
We provide permanent, radioactive implants –seeds- which are used in LDR brachytherapy, mainly in the treatment of localized prostate cancer where they destroy the cancer cells.
Available is also treatment planning software, ultrasound scanners and a complete range of accessories, as well as professional training.